Treatment of canine tumor infiltrating lymphocytes with anti-PD-L1 enhanced IFN-γ production, suggesting that blockade with this antibody may provide therapeutic benefit for dogs harboring PD-L1+ tumors [31]. This evidence concerns the gene CD274 and neoplasm.